BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 38648183)

  • 1. Low MBOAT7 expression, a genetic risk for MASH, promotes a pro-fibrotic pathway involving hepatocyte TAZ upregulation.
    Moore MP; Wang X; Kennelly JP; Shi H; Ishino Y; Kano K; Aoki J; Cherubini A; Ronzoni L; Guo X; Chalasani NP; Khalid S; Saleheen D; Mitsche MA; Rotter JI; Yates KP; Valenti L; Kono N; Tontonoz P; Tabas I
    Hepatology; 2024 May; ():. PubMed ID: 38776184
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Cell Specific Effect of MBOAT7 MAFLD-risk Variant on Immune Cells.
    Pan Z; Alharthi J; Bayoumi A; George J; Eslam M
    Front Biosci (Landmark Ed); 2024 Apr; 29(4):148. PubMed ID: 38682204
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Membrane-bound O-acyltransferase 7 (MBOAT7)-driven phosphatidylinositol remodeling in advanced liver disease.
    Varadharajan V; Massey WJ; Brown JM
    J Lipid Res; 2022 Jul; 63(7):100234. PubMed ID: 35636492
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Liver Involvement in Patients with Rare
    Ronzoni L; Mureddu M; Malvestiti F; Moretti V; Bianco C; Periti G; Baldassarri M; Ariani F; Carrer A; Pelusi S; Renieri A; Prati D; Valenti L
    Genes (Basel); 2023 Aug; 14(8):. PubMed ID: 37628684
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Membrane-bound
    Varadharajan V; Ramachandiran I; Massey WJ; Jain R; Banerjee R; Horak AJ; McMullen MR; Huang E; Bellar A; Lorkowski SW; Gulshan K; Helsley RN; James I; Pathak V; Dasarathy J; Welch N; Dasarathy S; Streem D; Reizes O; Allende DS; Smith JD; Simcox J; Nagy LE; Brown JM
    Elife; 2024 Apr; 12():. PubMed ID: 38648183
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Membrane Bound O-Acyltransferase 7 (MBOAT7) Shapes Lysosomal Lipid Homeostasis and Function to Control Alcohol-Associated Liver Injury.
    Varadharajan V; Ramachandiran L; Massey WJ; Jain R; Banerjee R; Horak AJ; McMullen MR; Huang E; Bellar A; Lorkowski SW; Guilshan K; Helsley RN; James I; Pathak V; Dasarathy J; Welch N; Dasarathy S; Streem D; Reizes O; Allende DS; Smith JD; Simcox J; Nagy LE; Brown JM
    bioRxiv; 2024 Jan; ():. PubMed ID: 37808828
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Obesity-linked suppression of membrane-bound
    Helsley RN; Varadharajan V; Brown AL; Gromovsky AD; Schugar RC; Ramachandiran I; Fung K; Kabbany MN; Banerjee R; Neumann CK; Finney C; Pathak P; Orabi D; Osborn LJ; Massey W; Zhang R; Kadam A; Sansbury BE; Pan C; Sacks J; Lee RG; Crooke RM; Graham MJ; Lemieux ME; Gogonea V; Kirwan JP; Allende DS; Civelek M; Fox PL; Rudel LL; Lusis AJ; Spite M; Brown JM
    Elife; 2019 Oct; 8():. PubMed ID: 31621579
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Loss of hepatic Mboat7 leads to liver fibrosis.
    Thangapandi VR; Knittelfelder O; Brosch M; Patsenker E; Vvedenskaya O; Buch S; Hinz S; Hendricks A; Nati M; Herrmann A; Rekhade DR; Berg T; Matz-Soja M; Huse K; Klipp E; Pauling JK; Wodke JA; Miranda Ackerman J; Bonin MV; Aigner E; Datz C; von Schönfels W; Nehring S; Zeissig S; Röcken C; Dahl A; Chavakis T; Stickel F; Shevchenko A; Schafmayer C; Hampe J; Subramanian P
    Gut; 2021 May; 70(5):940-950. PubMed ID: 32591434
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The MBOAT7-TMC4 Variant rs641738 Increases Risk of Nonalcoholic Fatty Liver Disease in Individuals of European Descent.
    Mancina RM; Dongiovanni P; Petta S; Pingitore P; Meroni M; Rametta R; Borén J; Montalcini T; Pujia A; Wiklund O; Hindy G; Spagnuolo R; Motta BM; Pipitone RM; Craxì A; Fargion S; Nobili V; Käkelä P; Kärjä V; Männistö V; Pihlajamäki J; Reilly DF; Castro-Perez J; Kozlitina J; Valenti L; Romeo S
    Gastroenterology; 2016 May; 150(5):1219-1230.e6. PubMed ID: 26850495
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MBOAT7-driven lysophosphatidylinositol acylation in adipocytes contributes to systemic glucose homeostasis.
    Massey WJ; Varadharajan V; Banerjee R; Brown AL; Horak AJ; Hohe RC; Jung BM; Qiu Y; Chan ER; Pan C; Zhang R; Allende DS; Willard B; Cheng F; Lusis AJ; Brown JM
    J Lipid Res; 2023 Apr; 64(4):100349. PubMed ID: 36806709
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A metabolic associated fatty liver disease risk variant in MBOAT7 regulates toll like receptor induced outcomes.
    Alharthi J; Bayoumi A; Thabet K; Pan Z; Gloss BS; Latchoumanin O; Lundberg M; Twine NA; McLeod D; Alenizi S; Adams LA; Weltman M; Berg T; Liddle C; George J; Eslam M
    Nat Commun; 2022 Dec; 13(1):7430. PubMed ID: 36473860
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Determination of tissue contributions to the circulating lipid pool in cold exposure via systematic assessment of lipid profiles.
    Jain R; Wade G; Ong I; Chaurasia B; Simcox J
    J Lipid Res; 2022 Jul; 63(7):100197. PubMed ID: 35300982
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MetaboAnalyst 5.0: narrowing the gap between raw spectra and functional insights.
    Pang Z; Chong J; Zhou G; de Lima Morais DA; Chang L; Barrette M; Gauthier C; Jacques PÉ; Li S; Xia J
    Nucleic Acids Res; 2021 Jul; 49(W1):W388-W396. PubMed ID: 34019663
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quantitative trait locus mapping identifies the Gpnmb gene as a modifier of mouse macrophage lysosome function.
    Robinet P; Ritchey B; Lorkowski SW; Alzayed AM; DeGeorgia S; Schodowski E; Traughber CA; Smith JD
    Sci Rep; 2021 May; 11(1):10249. PubMed ID: 33986446
    [TBL] [Abstract][Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.